News Tamoxifen reduces breast cancer by a third in high risk women BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7365.613/a (Published 21 September 2002) Cite this as: BMJ 2002;325:613 Article Related content Metrics Responses Peer review Related articles Review The operation was a success (but the patients died) Published: 21 September 2002; BMJ 325 doi:10.1136/bmj.325.7365.664 See more Breast cancer: Inaction on inequalities has led to unequal progress, say experts BMJ April 16, 2024, 385 q854; DOI: https://doi.org/10.1136/bmj.q854 Cancer: Fast tracked drugs often do not improve clinical outcomes, say researchers BMJ April 08, 2024, 385 q818; DOI: https://doi.org/10.1136/bmj.q818 NHS rolls out fast tracked immunotherapy for advanced endometrial cancer BMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557 Teledentistry may help in detecting oral cancers in current GP and dentist shortages BMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512 UK’s progress on cancer survival has slowed in past decade, figures show BMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290
